Deep in the lungs, resident memory B cells stand guard against influenza reinfection—but whether they remain there may depend ...
A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...
Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug ...
Researchers at the Hebrew University of Jerusalem suggest that vertical green walls, along with AI-inspired technology, offer ...
EpiBiologics, a leader in tissue-selective extracellular protein degradation, today announced that the first patient has been dosed with EPI-326 in its global Phase 1 clinical study. EPI-326 is the ...
Six poster presentations showcase Zymeworks’ next-generation ADC programs, including multiple first-in-class pan-RAS ...
STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing solid tumor PDX models, with improved efficacy ...
How does preventing cirrhosis lower the risk of liver cancer mortality? Early intervention, viral hepatitis treatment, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results